152 related articles for article (PubMed ID: 10222599)
1. Flavobacterium meningosepticum bacteremia: an analysis of 16 cases.
Liu CE; Wong WW; Yang SP; Wang FD; Fung CP; You KW; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Mar; 62(3):125-32. PubMed ID: 10222599
[TBL] [Abstract][Full Text] [Related]
2. [Elizabethkingia meningosepticum bacteremia in a patient with Bardet-Biedl syndrome and chronic renal failure].
Bayrak B; Fıncanci M; Bınay UD; Çımen C; Özkantar Ünlügüneş GU
Mikrobiyol Bul; 2014 Jul; 48(3):495-500. PubMed ID: 25052117
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods.
Chang JC; Hsueh PR; Wu JJ; Ho SW; Hsieh WC; Luh KT
Antimicrob Agents Chemother; 1997 Jun; 41(6):1301-6. PubMed ID: 9174188
[TBL] [Abstract][Full Text] [Related]
4. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review.
Bloch KC; Nadarajah R; Jacobs R
Medicine (Baltimore); 1997 Jan; 76(1):30-41. PubMed ID: 9064486
[TBL] [Abstract][Full Text] [Related]
5. In vitro antibiotic synergy against Flavobacterium meningosepticum: implications for therapeutic options.
Di Pentima MC; Mason EO; Kaplan SL
Clin Infect Dis; 1998 May; 26(5):1169-76. PubMed ID: 9597247
[TBL] [Abstract][Full Text] [Related]
6. Flavobacterium spp. organisms as opportunistic bacterial pathogens during advanced HIV disease.
Manfredi R; Nanetti A; Ferri M; Mastroianni A; Coronado OV; Chiodo F
J Infect; 1999 Sep; 39(2):146-52. PubMed ID: 10609533
[TBL] [Abstract][Full Text] [Related]
7. Biofilm production, use of intravascular indwelling catheters and inappropriate antimicrobial therapy as predictors of fatality in Chryseobacterium meningosepticum bacteraemia.
Lin PY; Chen HL; Huang CT; Su LH; Chiu CH
Int J Antimicrob Agents; 2010 Nov; 36(5):436-40. PubMed ID: 20933186
[TBL] [Abstract][Full Text] [Related]
8. Outbreak of nosocomial Flavobacterium meningosepticum respiratory infections associated with use of aerosolized polymyxin B.
Brown RB; Phillips D; Barker MJ; Pieczarka R; Sands M; Teres D
Am J Infect Control; 1989 Jun; 17(3):121-5. PubMed ID: 2545119
[TBL] [Abstract][Full Text] [Related]
9. Flavobacterium meningosepticum sepsis: disease due to bacteria with unusual antibiotic susceptibility.
Harrington SP; Perlino CA
South Med J; 1981 Jun; 74(6):764-6. PubMed ID: 7244763
[TBL] [Abstract][Full Text] [Related]
10. Flavobacterium meningosepticum.
Ratner H
Infect Control; 1984 May; 5(5):237-9. PubMed ID: 6563023
[TBL] [Abstract][Full Text] [Related]
11. Relapse of catheter-related Flavobacterium meningosepticum bacteremia demonstrated by DNA macrorestriction analysis.
Sader HS; Jones RN; Pfaller MA
Clin Infect Dis; 1995 Oct; 21(4):997-1000. PubMed ID: 8645856
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and bacteriological study on Flavobacterium meningosepticum (author's transl)].
Igari J; Kosakai N; Oguri T
Jpn J Antibiot; 1977 Mar; 30(3):242-9. PubMed ID: 857060
[TBL] [Abstract][Full Text] [Related]
13. Brevundimonas vesicularis bacteremia resistant to trimethoprim-sulfamethoxazole and ceftazidime in a tertiary hospital in southern Taiwan.
Zhang CC; Hsu HJ; Li CM
J Microbiol Immunol Infect; 2012 Dec; 45(6):448-52. PubMed ID: 22516745
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics, antimicrobial susceptibilities, and outcomes of patients with Chryseobacterium indologenes bacteremia in an intensive care unit.
Chou DW; Wu SL; Lee CT; Tai FT; Yu WL
Jpn J Infect Dis; 2011; 64(6):520-4. PubMed ID: 22116334
[TBL] [Abstract][Full Text] [Related]
15. Capnocytophaga bacteremia: clinical features of patients and antimicrobial susceptibility of isolates.
Lin RD; Hsueh PR; Chang SC; Luh KT
J Formos Med Assoc; 1998 Jan; 97(1):44-8. PubMed ID: 9481064
[TBL] [Abstract][Full Text] [Related]
16. Atypical Chryseobacterium meningosepticum and meningitis and sepsis in newborns and the immunocompromised, Taiwan.
Chiu CH; Waddingdon M; Greenberg D; Schreckenberger PC; Carnahan AM
Emerg Infect Dis; 2000; 6(5):481-6. PubMed ID: 10998378
[TBL] [Abstract][Full Text] [Related]
17. Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan.
Lin YT; Chiu CH; Chan YJ; Lin ML; Yu KW; Wang FD; Liu CY
Scand J Infect Dis; 2009; 41(9):628-34. PubMed ID: 19579148
[TBL] [Abstract][Full Text] [Related]
18. Analysis of an outbreak due to Chryseobacterium meningosepticum in a neonatal intensive care unit.
Tekerekoglu MS; Durmaz R; Ayan M; Cizmeci Z; Akinci A
New Microbiol; 2003 Jan; 26(1):57-63. PubMed ID: 12578312
[TBL] [Abstract][Full Text] [Related]
19. Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes.
Sligl W; Taylor G; Brindley PG
Int J Infect Dis; 2006 Jul; 10(4):320-5. PubMed ID: 16460982
[TBL] [Abstract][Full Text] [Related]
20. Flavobacterium indologenes bacteremia: clinical and microbiological characteristics.
Hsueh PR; Hsiue TR; Wu JJ; Teng LJ; Ho SW; Hsieh WC; Luh KT
Clin Infect Dis; 1996 Sep; 23(3):550-5. PubMed ID: 8879779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
